Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome

Published:2021-08-26 Issue:8 Volume:4 Page:e2122597
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Björklund Erik¹²,Malm Carl Johan¹³,Nielsen Susanne J.¹³,Hansson Emma C.¹³,Tygesen Hans¹²,Romlin Birgitta S.¹⁴,Martinsson Andreas¹⁵,Omerovic Elmir¹⁵,Pivodic Aldina⁶⁷,Jeppsson Anders¹³

Affiliation:

1. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden

2. Department of Medicine, South Älvsborg Hospital, Borås, Sweden

3. Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden

4. Department of Anesthesiology and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden

5. Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden

6. Statistiska Konsultgruppen, Gothenburg, Sweden

7. Department of Ophthalmology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2783510/bjrklund_2021_oi_210669_1629379866.57934.pdf

Reference26 articles.

1. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease.;Levine;J Am Coll Cardiol,2016

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).;Valgimigli;Eur Heart J,2018

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.;Held;J Am Coll Cardiol,2011

4. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non–ST-elevation acute coronary syndrome.;Fox;Circulation,2004

5. A meta-analysis comparing aspirin alone versus dual antiplatelet therapy for the prevention of venous graft failure following coronary artery bypass surgery.;Hesterberg;Cardiovasc Revasc Med,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postdischarge major bleeding, myocardial infarction, and mortality risk after coronary artery bypass grafting;Heart;2023-12-26

2. Antiplatelet therapy around CABG: the latest evidence;Current Opinion in Cardiology;2023-09-21

3. The Management and Antithrombotic Strategies of Patients with Coronary Artery Disease and High Bleeding Risk;Current Cardiology Reports;2023-06-07

4. Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial;American Heart Journal;2023-05

5. Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes;Journal of Clinical Medicine;2022-05-26